Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.

MLA

Haller, Paul M., et al. “Bleeding and Ischaemic Outcomes in Patients Treated with Dual or Triple Antithrombotic Therapy: Systematic Review and Meta-Analysis.” European Heart Journal. Cardiovascular Pharmacotherapy, vol. 5, no. 4, Oct. 2019, pp. 226–36. EBSCOhost, https://doi.org/10.1093/ehjcvp/pvz021.

APA

Haller, P. M., Sulzgruber, P., Kaufmann, C., Geelhoed, B., Tamargo, J., Wassmann, S., Schnabel, R. B., Westermann, D., Huber, K., Niessner, A., & Gremmel, T. (2019). Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis. European Heart Journal. Cardiovascular Pharmacotherapy, 5(4), 226–236. https://doi.org/10.1093/ehjcvp/pvz021

Chicago

Haller, Paul M, Patrick Sulzgruber, Christoph Kaufmann, Bastiaan Geelhoed, Juan Tamargo, Sven Wassmann, Renate B Schnabel, et al. 2019. “Bleeding and Ischaemic Outcomes in Patients Treated with Dual or Triple Antithrombotic Therapy: Systematic Review and Meta-Analysis.” European Heart Journal. Cardiovascular Pharmacotherapy 5 (4): 226–36. doi:10.1093/ehjcvp/pvz021.